Benedikt Trabold

Dr. Benedikt Trabold


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Injury
Verified
Journal Article
Closed access
RLR. Leberle
R. Leberle
AEA. Ernstberger
A. Ernstberger
MLMarkus Loibl
Markus Loibl
JMJ. Merkl
J. Merkl
MBM. Bunz
M. Bunz
BTBenedikt Trabold
Benedikt Trabold

13 May 2013 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
CNChristoph Niessen
Christoph Niessen
EJErnst Michael JUNG
Ernst Michael JUNG
Andreas G. SchreyerAndreas G. Schreyer
Andreas G. Schreyer
WWWalter A Wohlgemuth
Walter A Wohlgemuth
BTBenedikt Trabold
Benedikt Trabold
PWPhilipp Wiggermann
Philipp Wiggermann
Irreversible electroporation (IRE) is a new minimally invasive tumor ablation technique which induces irreversible disruption of cell membrane integrity by changing the transmembrane potential resulting in cell death. Irreversible electroporation is currently undergoing clinical investigation as local tumor therapy for malignant liver and lung lesions. This is the first case report to describe the successful palliative ablation of a presacral recurrence of an endometrial cancer to achieve locoregional tumor control and pain relief.

25 July 2014 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
CWChristoph Hr Wiese
Christoph Hr Wiese
KFKirstin Fragemann
Kirstin Fragemann
PKPeter C Keil
Peter C Keil
ABAnika C Bundscherer
Anika C Bundscherer
NLNicole Lindenberg
Nicole Lindenberg
BTBenedikt Trabold
Benedikt Trabold
Demographic development is accompanied by an increasingly aging society. Concerning medical education, the treatment of older people as well as the scientific research and exploration of ageing aspects in the coming years need to be considered. Aim of the study was to ascertain medical students’ knowledge, interest, and attitudes regarding older patients and geriatric medicine.

1 August 2013 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
BTBenedikt Trabold
Benedikt Trabold
PWPhilipp Wiggermann
Philipp Wiggermann
DADerya Akyol
Derya Akyol
EJErnst-Michael Jung
Ernst-Michael Jung
CNChristoph Nießen
Christoph Nießen
CWChristoph Wiese
Christoph Wiese

Verified
Journal Article
Open access
PDF file
SHSophie-Marie Anna Haile
Sophie-Marie Anna Haile
MGMichael Gruber
Michael Gruber
GBGabriele Bollwein
Gabriele Bollwein
BTBenedikt Trabold
Benedikt Trabold
This study examines how different concentrations of arginine vasopressin (AVP) and its preservative chlorobutanol (ClB) impact the immune functions of human polymorphonuclear neutrophils (PMNs), which are crucial in the immune response, particularly in sepsis. Using a model to simulate the physiological, sepsis-related, and therapeutic AVP levels in plasma, we analysed how AVP and ClB affect PMN activities, including reactive oxygen species (ROS) production, NETosis, antigen expression, and migration. PMNs were isolated from whole human blood and assessed using flow cytometry and live cell imaging. The results indicated that neither AVP nor ClB significantly affected PMN viability, antigen expression, NETosis, or ROS production in response to N-Formylmethionine-leucyl-phenylalanine, or fMLP, and tumour necrosis factor alpha. In the migration assays, concentration-dependent effects were observed. At physiological AVP levels, PMN migration showed no reduction, while the sepsis-associated AVP levels initially reduced migration before returning to the baseline or even increasing. The therapeutic AVP concentrations showed similar migration to that in the controls, while high concentrations progressively inhibited migration. ClB, regardless of its concentration, enhanced PMN migration. These findings suggest that AVP during sepsis may impair PMN migration, potentially contributing to tissue damage and systemic complications. This highlights AVP’s role as a possible immune modulator in complex immune responses.